No public access
master's thesis
Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling

Kristina Vukušić (2016)
University of Rijeka
Department of Biotechnology
Cite this document...

Vukušić, K. (2016). Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling (Master's thesis). Retrieved from https://urn.nsk.hr/urn:nbn:hr:193:483208

Vukušić, Kristina. "Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling." Master's thesis, University of Rijeka, 2016. https://urn.nsk.hr/urn:nbn:hr:193:483208

Vukušić, Kristina. "Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling." Master's thesis, University of Rijeka, 2016. https://urn.nsk.hr/urn:nbn:hr:193:483208

Vukušić, K. (2016). 'Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling', Master's thesis, University of Rijeka, accessed 26 March 2019, https://urn.nsk.hr/urn:nbn:hr:193:483208

Vukušić K. Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling [Master's thesis]. Rijeka: University of Rijeka; 2016 [cited 2019 March 26] Available at: https://urn.nsk.hr/urn:nbn:hr:193:483208

K. Vukušić, "Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling", Master's thesis, University of Rijeka, Rijeka, 2016. Available at: https://urn.nsk.hr/urn:nbn:hr:193:483208